Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a…
Emergency Use Listing by WHO will expedite global access and availability of COVAXIN® worldwide. The WHO's Emergency Use Listing (EUL) for…
Data from 25,800 participants, received vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well tolerated.…